Malnutrition indices and prognosis across the BMI range in patients with HFpEF: insights from the PARAGON-HF trial

被引：0

作者：

Lu, H. ^{[1
]}

Claggett, B. ^{[1
]}

Minamisawa, M. ^{[2
]}

Kalayci, A. ^{[1
]}

Foa, A. ^{[1
]}

Desai, A. ^{[1
]}

Mcmurray, J. J. V. ^{[3
]}

Vaduganathan, M. ^{[1
]}

Hegde, S. M. ^{[1
]}

Solomon, S. D. ^{[1
]}

Skali, H. ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Shinshu Univ, Sch Med, Matsumoto, Nagano, Japan

[3] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：70 / 70

页数：1

共 50 条

[31] Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
Rohde, Luis E.
Claggett, Brian L.
Wolsk, Emil
Packer, Milton
Zile, Michael
Swedberg, Karl
Rouleau, Jean
Pfeffer, Marc A.
Desai, Akshay S.
Lund, Lars H.
Kober, Lars
Anand, Inder
Merkely, Bela
Senni, Michele
Shi, Victor
Rizkala, Adel
Lefkowitz, Martin
McMurray, John J., V
Solomon, Scott D.
CIRCULATION-HEART FAILURE, 2021, 14 (03) : 361 - 371
[32] What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction
Rettl, Rene
Dachs, Theresa-Marie
Duca, Franz
Binder, Christina
Dusik, Fabian
Seirer, Benjamin
Schoenauer, Johannes
Kronberger, Christina
Camuz Ligios, Luciana
Hengstenberg, Christian
Derkits, Nina
Kastner, Johannes
Badr Eslam, Roza
Bonderman, Diana
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 15
[33] Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF
Peikert, Alexander
Vaduganathan, Muthiah
Mc Causland, Finnian
Claggett, Brian L.
Chatur, Safia
Packer, Milton
Pfeffer, Marc A.
Zannad, Faiez
Lefkowitz, Martin P.
Pieske, Burkert
Duengen, Hans-Dirk
McMurray, John J. V.
Solomon, Scott D.
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 794 - 803
[34] High sensitivity troponin and treatment with sacubitril/valsartan in heart failure patients with preserved ejection fraction. The PARAGON-HF trial
Gori, M. Mauro
Senni, M.
Claggett, B.
Maggioni, A. P.
Zile, M.
Prescott, M. F.
Van Veldhuisen, D.
Zannad, F.
Pieske, B.
Lam, C.
Rouleau, J.
Jhund, P.
Mcmurray, J.
Solomon, S. D.
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 271 - 272
[35] Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
Pabon, Maria A.
Cunningham, Jonathan W.
Claggett, Brian L.
Packer, Milton
Zile, Michael
Pfeffer, Marc A.
Lefkowitz, Martin
Shi, Victor
Rizkala, Adel
McMurray, John J., V
Solomon, Scott D.
Vaduganathan, Muthiah
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) : 672 - 677
[36] Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF
McMurray, John J., V
Jackson, Alice M.
Lam, Carolyn S. P.
Redfield, Margaret M.
Anand, Inder S.
Ge, Junbo
Lefkowitz, Marty P.
Maggioni, Aldo P.
Martinez, Felipe
Packer, Milton
Pfeffer, Marc A.
Pieske, Burkert
Rizkala, Adel R.
Sabarwal, Shalini, V
Shah, Amil M.
Shah, Sanjiv J.
Shi, Victor C.
van Veldhuisen, Dirk J.
Zannad, Faiez
Zile, Michael R.
Cikes, Maja
Goncalvesova, Eva
Katova, Tzvetana
Kosztin, Anamaria
Lelonek, Malgorzata
Sweitzer, Nancy
Vardeny, Orly
Claggett, Brian
Jhund, Pardeep S.
Solomon, Scott D.
CIRCULATION, 2020, 141 (05) : 338 - 351
[37] Conventional medical therapies in patients with heart failure across different risk for transthyretin amyloid cardiomyopathy in the DELIVER, PARAGON-HF and TOPCAT Americas trials
Inciardi, Riccardo Maria
Vaduganathan, M.
Claggett, B.
Abouezzeddine, O. F.
Borlaug, B. A.
Desay, A. S.
Jhund, P. S.
Lam, C. S. P.
Minamisawa, M.
Redfield, M. M.
Shah, S. J.
Fontana, M.
Mcmurray, J. J. V.
Solomon, S. D.
EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 67 - 68
[38] Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trial
Chatur, Safia
Vaduganathan, Muthiah
Peikert, Alexander
Claggett, Brian L.
McCausland, Finnian R.
Skali, Hicham
Pfeffer, Marc A.
Beldhuis, Iris E.
Kober, Lars
Seferovic, Petar
Lefkowitz, Martin
McMurray, John J., V
Solomon, Scott D.
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1906 - 1914
[39] Sex-based differences in cardiac structure and function in heart failure with preserved ejection fraction: Insights from the PARAGON-HF Echocardiographic Sub-Study
Shah, A. Amil
Cikes, M.
Prasad, N.
Claggett, B.
O'meara, E.
Zile, M.
Lam, C.
Shah, S.
Mullens, W.
Sweitzer, N.
Redfield, M.
Mcmurray, J.
Solomon, S.
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 10 - 11
[40] Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HF
Solano, Simone
Yang, Mingming
Tolomeo, Paolo
Kondo, Toru
Shen, Li
Jhund, Pardeep S.
Anand, Inder S.
Desai, Akshay S.
Lam, Carolyn S. P.
Maggioni, Aldo P.
Martinez, Felipe A.
Rouleau, Jean L.
Vaduganathan, Muthiah
van Veldhuisen, Dirk J.
Zannad, Faiez
Zile, Michael R.
Packer, Milton
Solomon, Scott D.
Mcmurray, John J. V.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (01):

← 1 2 3 4 5 →